The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 333:732-733 September 14, 1995 Number 11
NextNext

Serum Antibodies to the Deleted Dystrophin Sequence after Cardiac Transplantation in a Patient with Becker's Muscular Dystrophy

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
To the Editor: Becker's muscular dystrophy and Duchenne's muscular dystrophy are allelic disorders caused by mutations of the dystrophin gene at Xp21.1 The 400-kd dystrophin is expressed most abundantly in the plasma membranes of skeletal and cardiac muscle fibers but is absent in patients with severe Duchenne's muscular dystrophy and in mdx mice. The expression of a truncated, "semifunctional" dystrophin molecule is usually associated with Becker's muscular dystrophy, which is milder than Duchenne's muscular dystrophy.2

It is not clear whether the full-length dystrophin molecule induces a specific immune response against the deleted sequence in a patient with Becker's muscular dystrophy. . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.